MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
A single rising dose study to assess the safety, tolerability, pharmacokinetics and
pharmacodynamics of MK-1006 in Japanese participants with Type 2 Diabetes Mellitus (T2DM).
The primary hypothesis of the study is that single doses of MK-1006 will be sufficiently safe
and well tolerated, based on the assessment of clinical and laboratory evaluations and
adverse experiences, in Japanese participants with T2DM.